Moderna
MRNA
HK$237.69
Share price
5.54%
Change (1 day)
-73.76%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.
Market capitalization of Moderna (MRNA)
Market cap: HK$91.92 Billion
As of July 2025 Moderna has a market cap of HK$91.92 Billion. This makes Moderna the world's 1633th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Moderna from 2018 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | HK$91.92 B | -23.33% |
| 2024 | HK$119.88 B | -59.52% |
| 2023 | HK$296.14 B | -45.07% |
| 2022 | HK$539.16 B | -32.85% |
| 2021 | HK$802.96 B | 150.55% |
| 2020 | HK$320.47 B | 525.11% |
| 2019 | HK$51.26 B | 30.39% |
| 2018 | HK$39.31 B |
End of Day market cap according to different sources
On Jul 1st, 2025 the market cap of Moderna was reported to be:
HK$87.09 Billion
HK$87.09 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Regulus Therapeutics RGLS | HK$4.43 B | -95.18% | 🇺🇸 USA |
 Merck MRK | HK$1.623 T | 1,666.43% | 🇺🇸 USA |
 Athersys ATHX | HK$6.54 M | -99.99% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | HK$337.51 B | 267.17% | 🇺🇸 USA |
 Novartis NVS | HK$1.925 T | 1,995.00% | 🇨🇭 Switzerland |
 Arrowhead Pharmaceuticals
ARWR | HK$18.32 B | -80.07% | 🇺🇸 USA |
 Johnson & Johnson JNJ | HK$2.937 T | 3,095.96% | 🇺🇸 USA |
 Dicerna Pharmaceuticals DRNA | HK$23.37 B | -74.57% | 🇺🇸 USA |